medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2011, Número 11-12

<< Anterior Siguiente >>

Medicina & Laboratorio 2011; 17 (11-12)


Guía de atención de la leishmaniasis
Ministerio de la Protección Social

Idioma: Español
Referencias bibliográficas: 102
Paginas: 553-580
Archivo PDF: 666.75 Kb.


FRAGMENTO

La leishmaniasis es un problema creciente de salud pública en el contexto mundial. En Colombia, la situación es de alarma debido al incremento de casos de leishmaniasis cutánea que se viene registrando desde 2003 y el cambio en el patrón epidemiológico dado por la aparición de nuevos focos, el proceso creciente de domiciliación y urbanización del ciclo de transmisión.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbio. Infect Dis 2004; 27: 305-318.

  2. Ministerio de la Protección Social. Programa leishmaniasis. Oficina de ETV.

  3. Bejarano EE, Uribe S, Rojas W, Vélez D. Phlebotomine sand flies (Diptera: Psychodidae) associated with the appearance of urban Leishmaniasis in the city of Sincelejo. Mem Inst Oswaldo Cruz 2002; 97: 645-647.

  4. Pearson RD, Wheeler DA, Harrison LH, Kay HD. The immunobiology of leishmaniasis. Rev Infect Dis 1983; 5: 907-927.

  5. Miranda MC, Posso CX, Rojas CA. Manual de normas y procedimientos para la atención de la leishmaniasis en los municipios de Valle del Cauca. Secretaria Departamental de Salud, Gobernación del Valle del Cauca y Centro Internacional de Entrenamiento e Investigaciones Médicas. Cali, Colombia. 2005.

  6. Young DG, Morales A, Kreutzer RD, Alexander JB, Corredor A, Tesh RB, Ferro de Carrasquilla C, de Rodríguez C. Isolations of Leishmania braziliensis (Kinetoplastida: Trypanosomatidae) from cryopreserved Colombian sand flies (Diptera: Psychodidae). J Med Entomol 1987; 5: 587-589.

  7. Montoya J, Ferro C. Flebótomos (Diptera:Psychodidae) de Colombia. In Amat G, Andrade MG, Fernández F. Insectos de Colombia VII. Academia Colombiana de Ciencias Exactas, Físicas y Naturales. Colección Jorge Álvarez Lleras No. 13. 199; Bogotá, Colombia.

  8. CIPA Group. Science and Technology Cooperation of US Agency for International Development and the Scientific and Technical Cooperation of the French Ministry of Foreign Affairs. http://cipa.snv.jussieu.fr/index.html.

  9. Wolff M, Galati EA. Description of Pintomyia limafalcaoae and Pintomyia antioquiensis, two new species of phlebotomine sand fly (Diptera, Psychodidae) from the Colombian Andes. Mem Inst Oswaldo Cruz 2002; 97: 317-324.

  10. Barreto M, Burbano ME, Young DG. Description of Lutzomyia (Trichophoromyia) pabloi n. sp. and the female of L. howardi (Diptera: Psychodidae) from Colombia. J Med Entomol 2002; 39: 601-604.

  11. Bejarano EE, Duque P, Vélez ID. Taxonomy and distribution of the series pia of the Lutzomyia verrucarum group (Diptera: Psychodidae), with a description of Lutzomyia emberain sp. J Med Entomol 2004; 41: 833-841.

  12. Bejarano E, Sierra D, Vélez ID. New findings on the geographic distribution of the L verrucarum group (Diptera: Psychodidae) in Colombia. Biomédica 2003; 3: 341-350.

  13. Relatoría Panel de Expertos. Universidad Nacional, Min Protección Social. Bogotá septiembre 16 de 2005. Nivel de evidencia 5, grado de recomendación D

  14. Corredor A., Gallego J, Tesh R. B, Morales A, Ferro C, Young D. G, Kreutzer R. D, Boshell J, Palau M. T, Cáceres E, Peláez D. Epidemiology of visceral leishmaniasis in Colombia. Am J Trop Med Hyg 1989; 5: 480-486.

  15. Travi B. L, Vélez I. D, Brutus L, Segura I, Jaramillo C, Montoya J. 1990. Lutzomyia evansi, an alternate vector of Leishmania chagasi in a Colombian focus of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1990; 84: 676-677.

  16. Grimaldi G, Tesh R. B, Mc Mahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 1989; 6: 687-725.

  17. Corredor A., Kreutzer R. D., Tesh R. B, Boshell J, Palau M. T, Cáceres E, Duque S, Peláez D, Rodríguez G, Nichols S, Hernández C. A, Morales A, Young D. G, Ferro C. Distribution and etiology of leishmaniasis in Colombia. Am J Trop Med Hyg 1990; 3: 206-214.

  18. Travi BL, Montoya J, Solarte Y, Lozano L, Jaramillo C. Leishmaniasis in Colombia. I. Studies on the phlebotomine fauna associated with endemic foci in the Pacific Coast region. Am J Trop Med Hyg 1988; 3: 261-266.

  19. Alexander B, Ferro C, Young DG, Morales A, Tesh RB. Mem. Ecology of phlebotomine sand flies (Diptera: Psychodidae) in a focus of Leishmania (Viannia) braziliensis in northeastern Colombia. Inst Oswaldo Cruz 1992.

  20. Santamaría E, Castillo M, Cárdenas R, Bello F, Ayala M, Ferrro C. Competencia vectorial de las especies del grupo verucatum (Diptera: Phychodidae) en un foco endémico de Leishmania braziliensis en Reventones, Cundinamarca. Biomédica 1999; 19: 1115-1126.

  21. Kreutzer R. D, Corredor A, Grimaldi G, Grogl M, Rowton E, Young D. G, Morales A, Mc Mahon-Pratt D, Guzmán H, Tesh R. B. Characterization of Leishmania colombiensis sp.n. (Kinetoplastida: Trypanosomatidae), a new parasite infecting humans, animals and phlebotomine sandflies in Colombia and Panama. Am J Trop Med Hyg 1991; 6: 662-675.

  22. Osorno-Mesa E. A., Morales A., Osorno F. de & Muñoz de Hoyos P. Phlebotominae de Colombia (Diptera, Psychodidae). VI. Descripción de Lutzomyia longiflocosa n.sp. y Lutzomyia bifoliata n.sp. Boletim do Museu de História Natural da Universidade Federal de Minas Gerais 1970; 6: 1-22.

  23. Pardo R, Ferro C, Lozano G, Lozano C, Cabrear O, Davies C. Flebotomos vectores de leishmaniasis cutánea y sus determinantes ecológicos en la zona cafetera del Depto. del Huila. Memorias XXVI Congreso de la sociedad colombiana de entomología. Bogotá-Colombia 1999; 147-163.

  24. Cárdenas R, Romo G, Santamaría E, Bello F, Ferro C. Lutzomya longiflocosa posible vector del foco de leishmaniasis cutánea en el municipio de planadas, zona cafetera del Depto. del Tolima. Biomédica 1999; 19: 239-244

  25. Alexander B, Usma MC, Cadena H, Quesada BL, Solarte Y, Roa W, Montoya J, Jaramillo C, Travi BL. Phlebotomine sandflies associated with a focus of cutaneous leishmaniasis in Valle del Cauca, Colombia. Med Vet Entomol 1995; 9: 273-278.

  26. Warburg A, Montoya-Lerma J, Jaramillo C, Cruz-Ruiz AL, Ostrovska K. Leishmaniasis vector potential of Lutzomyia spp. in Colombian coffee plantations. Med Vet Entomol 1991; 5: 9-16.

  27. Montoya-Lerma J, Cadena H, Segura I, Travi BL. Association of Lutzomyia columbiana (Diptera: Psychodidae) with a leishmaniasis focus in Colombia due to species of the Leishmania mexicana complex. Mem Inst Oswaldo Cruz 1999; 94: 277-283.

  28. Davies CR, Reithinger R, Campbell-Lendrum D, Feliciangeli D, Borges R, Rodríguez N. The epidemiology and control of leishmaniasis in Andean countries. Cad Saude Publica 2000; 16: 925-950.

  29. Travi BL, Adler GH, Lozano M, Cadena H, Montoya- Lerma J. Impact of habitat degradation on phlebotominae (Diptera: Psychodidae) of tropical dry forests in Northern Colombia. J Med Entomol 2002; 39: 451-456.

  30. López Y, Osorio L, Álvarez G, Rojas J, Jiménez F, Gómez C, Ferro C. Sandfly Lutzomyia longipalpis in a cutaneous leishmaniasis focus in central Colombia. Mem Inst Oswaldo Cruz 1996; 91: 415-419.

  31. Desjeuxn P. The increase in risk factor for leishmaniasis worldwide.Trans R Soc Trop Med Hyg 200; 95: 239-243.

  32. Vélez ID. III simposio nacional de actualización e investigación en ciencias biomédicas. Universidad de la sabana Bogotá, Agoto 11-13 de 2005. Nivel de evidencia 5, grado de recomendación D.

  33. Barreto, A. C. et al. Leishmania mexicana in Proechimys iheringi denigratus Moojen (Rodentia, Echimyidae) in a region endemic for american cutaneous leishmaniasis. Rev Soc Bras Med Trop 1985; 18: 243-246.

  34. Alexander B, Agudelo LA, Navarro F, Ruiz F, Molina J, Aguilera G, Quiñónez ML. Phlebotomine sandflies and leishmaniasis risks in Colombian coffee plantations under two systems of cultivation. Med Vet Entomol 2001; 15: 364-373.

  35. Moreira ED Jr, de Souza VM, Sreenivasan M, Lopes NL, Barreto RB, de Carvalho LP. 2003. Peridomestic risk factors for canine leishmaniasis in urban dwellings: new findings from a prospective study in Brazil. Am J Trop Med Hyg 2003; 69: 393-397.

  36. Vélez, I. Hendereich, E. Romano, Agudelo, S. Gender and Leishmaniasis in Colombia: a redefinition of existing concepts. April 1996. WHO-TDR. PECET.

  37. Alexander B, Lozano C, Barker DC, McCann SH, Adler GH. Detection of Leishmania (Viannia) braziliensis complex in wild mammals from Colombian coffee plantations by PCR and DNA hybridization. Acta Trop 1998; 69: 41-50.

  38. Reithinger R, Davies CR. Is the domestic dog (Canis familiaris) a reservoir host of American cutaneous leishmaniasis? A critical review of the current evidence. Am J Trop Med Hyg 1999; 61: 530-541.

  39. Montoya-Lerma J, Palacios R, Osorio L, Jaramillo C, Cadena H. Further evidence of humans as source of Leishmania viannia for sandflies. Mem Inst Oswaldo Cruz 1998; 96: 735-736.

  40. Vélez I.D 2001. La lesihmaniasis en Colombia: de la selva a la ciudad. Memorias XXVIII Congreso de la sociedad colombiana de entomología, Pereira, Colombia. P 51-57 Nivel de evidencia 5, grado de recomendación D.

  41. Sandoval CM, Angulo VM., Gutiérrez, Muñoz G, Ferro C. Especies de Lutzomyia (Diptera:Psychodidae) posibles vectores de leishmaniasis en la ciudad de Bucaramanga, Santander, Colombia. Biomédica 1998; 18: 161-168.

  42. Pardo RH, Farieta S, Munstermann LE, Ferro C. Estudio preliminar de flebótomos de Villeta y Quebradanegra, Cundinamarca: sus implicaciones en salud pública. Biomedica 1996; 16: 293-302.

  43. Barreto M, Burbano ME, Barreto P. Lutzomyia sand flies (Diptera: Psychodidae) from middle and lower Putumayo Department, Colombia, with new records to the country. Mem Inst Oswaldo Cruz 2000 Sep-Oct; 95: 633-639.

  44. Agudelo LA, Uribe J, Sierra D, Ruiz F, Vélez ID. Presence of American cutaneous Leishmaniasis vectors surrounding the city of Medellin, Colombia. Mem Inst Oswaldo Cruz 2002; 97 (5): 641-642.

  45. Travi BL, Vélez ID, Brutus L, Segura I, Jaramillo C, Montoya J. Lutzomyia evansi, an alternate vector of Leishmania chagasi in a Colombian focus of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1990; 84: 676-677.

  46. Corredor A, Gallego JF, Tesh RB, Peláez D, Díaz A, Montilla M, Palau MT. Didelphis marsupialis, an apparent wild reservoir of Leishmania donovani chagasi in Colombia, South America. Trans R Soc Trop Med Hyg 1989; 83: 195.

  47. Travi BL, Jaramillo C, Montoya J, Segura I, Zea A, Goncalves A, Vélez ID. Didelphis marsupialis, an important reservoir of Trypanosoma (Schizotrypanum) cruzi and Leishmania (Leishmania) chagasi in Colombia. Am J Trop Med Hyg 1994; 50: 557-565.

  48. Travi BL, Tabares CJ, Cadena H, Ferro C, Osorio Y. Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies. Am J Trop Med Hyg 2001; 64: 119-124.

  49. Travi BL, Ferro C, Cadena H, Montoya-Lerma J, Adler GH. Canine visceral leishmaniasis: dog infectivity to sand flies from non-endemic areas. Res Vet Sci 2002; 72: 83-86.

  50. Bejarano EE, Uribe S, Rojas W, Vélez ID. Presence of Lutzomyia evansi, a vector of American visceral leish maniasis, in an urban area of the Colombian Caribbean coast. Trans R Soc Trop Med Hyg 2001; 95: 27-28.

  51. Costa, N. Stewart, J. et. al. Asymptomatic Human Carriers of Leishmania Chagasi. Am J Trop Med And Hyg 66 2002; 334-337.

  52. Costa, C. Gómez, M, et. Al. Competente of the human host as a reservoir for Leishmania chagasi. J Infect Dis 2004; 182: 997-1000.

  53. Rojas C.A. An ecosystem approach to human health and the prevention of cutaneous leishmaniasis in Tumaco, Colombia. Cad Saude Publica 2001; 17: Suppl: 193-200.

  54. Soto, J. et al. Efficacy of permethrin-impregnated uniforms in the prevention of malaria and leishmaniasis in colombian soldiers. Clin Infect Dis 1995; 21: 599-602.

  55. OMS. División de lucha contra las enfermedades tropicales. 1996. Manual de lucha contra la leishmaniasis visceral.

  56. Alexander B, Jaramillo C, Usma MC, Quesada BL, Cadena H, Roa W, Travi BL. An attempt to control Phlebotomine sand flies (Diptera: Psychodidae) by residual spraying with deltamethrin in a Colombian village. Mem Inst Oswaldo Cruz 1995; 90: 421-424.

  57. Grimaldi Jr G, and Tesh R. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 1993; 6: 230-250.

  58. Ashford, D. David, J. Freire, M. et. al. Studies on control of visceral Leishmaniasis: impact of dog control on canine and human visceral human leishamniasis in Jacobina, Bahía. Brazil. Am J Trop Med And Hyg 1998; 59: 53-57.

  59. Oliveira S and Araújo, T. Avaliacao das acoees de controle da leishmaniose visceral (calazar) em uma área endemica do estado da Bahia, Brasil (1995-2000). Cad Saude Pública 2003; 19: 1681-1690.

  60. Alten, B. Caglar, S. Kayns, S. Simsek, F. Evaluation of protective efficacy of KOTAB impregnated bednets for cutaneous leishmaniasis control in Southeast Anatolia-Turkey.

  61. Alexander B, Jaramillo C, Usma MC, Quesada BL, Cadena H, Roa W, Travi BL. An attempt to control Phlebotomine sand flies (Diptera: Psychodidae) by residual spraying with deltamethrin in a Colombian village. Mem Inst Oswaldo Cruz 1995; 90: 421-424.

  62. Kroeger, A. Villegas E, Avila, L. Insecticide impregnated curtainas to control domestic transmission of cutaneus leishmaniasis in Venezuela: cluster ramdomized trial. BMJ 2002 12; 325: 810-813.

  63. Corredor A, Rey M, Hernández C, Parra M. Leishmaniasis tegumentaria americana. Boletín Epidemiológico Nacional (Colombia), 1986.

  64. Calvopina M, Gómez EA, Uezato H, Kato H, Nonaka S, Hashiguchi Y. Atypical clinical variants in New World cutaneous leishmaniasis: disseminated, erysipeloid, and recidiva cutis due to Leishmania (V.) panamensis. Am J Trop Med Hyg 2005; 73: 281-284.

  65. Robinson RJ, Agudelo S, Muskus C, Alzate JF, Berberich C, Barker DC, Vélez ID. The method used to sample ulcers influences the diagnosis of cutaneous leishmaniasis.Trans R Soc Trop Med Hyg 2002; 96: S169-171. Nivel de evidencia 2B, grado de recomendación B.

  66. Ramírez JR, Agudelo S, Muskus C, Alzate JF, Berberich C, Barker D, Vélez ID. Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis. J Clin Microbiol 2000; 38: 3768-3773. Nivel de evidencia 2B, grado recomendación B.

  67. Faber WR, Oskam L, van Gool T, Kroon NC, Knegt- Junk KJ, Hofwegen H, van der Wal AC, Kager PA. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 2003; 49: 70-74. Nivel de evidencia 2B, grado de recomendación B.

  68. Weigle KA, Labrada LA, Lozano C, Santrich C, Barker DC. PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia). J Clin Microbiol 2002; 40: 601-606. Nivel de evidencia 1B, grado de recomendación A.

  69. Saldanha AC, Romero GA, Guerra C, Merchan-Ha mann E, Macedo V de O. Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity. Rev Soc Bras Med Trop 2000; 33: 383-388.

  70. Chulay JD, Spencer HC, Mugambi M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg 1985; 34: 702-709.

  71. Hepburn NC, Nolan J, Fenn L, Herd RM, Neilson JM, Sutherland GR, Fox KA. Cardiac effects of sodium stibogluconate: myocardial, electrophysiological and biochemical studies. QJM 1994; 87: 465-472.

  72. Osorio LE, Castillo CM, Ochoa MT. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics. Am J Trop Med Hyg 1998; 59: 49-52.

  73. Santrich C, Segura I, Arias AL, Saravia NG. Mucosal disease caused by Leishmania braziliensis guyanensis. Am J Trop Med Hyg 1990; 42: 51-55.

  74. Saravia NG, Holguín AF, McMahon-Pratt D, D’Alessandro A. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg 198; 34: 714-720.

  75. Rodríguez G. Sarmiento L. Hernández C.A. Leishmaniasis mucosa y otras lesiones destructivas centrofaciales. Biomédica 1994; 14: 215-229.

  76. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD Jr. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154: 1003-1011.

  77. Engwerda CR, Ato M, Kaye PM. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol 2004; 20: 524-530.

  78. Badaró, Jones TC, Loren R, Cerf BJ, Sampaio D, Carvalho EM, Rocha H, Teixeira R, Johnson WD Jr. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986; 154: 639-649.

  79. Harms G, Zenk J, Martin S, Kokozidou M, Puschel W, Bienzle U, Seitz HM. Localized lymphadenopathy due to leishmanial infection. Infection 2001; 29: 355-356.

  80. Badaro R, Reed SG, Barral A, Orge G, Jones TC. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infectionspecific responses. Am J Trop Med Hyg 1986; 35: 72-78. Nivel de evidencia 2b, grado de recomendación B.

  81. Armijos RX, Weigel MM, Calvopina M, Mancheno M, Rodríguez R. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop 2004; 91: 153-160. Nivel de evidencia 1b, grado de recomendación D.

  82. Shazad B, Abbaszadeh B, Khamesipour A. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. Eur J Dermatol 2005; 15: 85-87. Nivel de evidencia 2b, grado de recomendación B.

  83. Soto JM, Toledo JT, Gutiérrez P, Arboleda M, Nicholls RS, Padilla JR, Berman JD, English CK, Grogl M. Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study. Am J Trop Med Hyg 2002; 66: 147-151. Nivel de evidencia 1b, grado de recomendación A.

  84. Soto J, Fuya P, Herrera R, Berman J. Topical paromomycin/ methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clin Infect Dis 1998; 26: 56-58. Nivel de evidencia 1b, grado de recomendación A.

  85. Montoya J, Palacios R, Osorio, l, Cadena H. Further evidence of human as source of Leishmania Viannia for sandflies Mem Inst Osw Cruz 1998; 93: 735-736.

  86. Soto J, Grogl M, Berman J, Olliaro P. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1994; 88: 695-698. Nivel de evidencia 2b, grado de recomendación B.

  87. Soto-Mancipe J, Grogl M, Berman JD. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis 1993; 16: 417-425. Nivel de evidencia 2b, grado de recomendación B.

  88. Hendrickx EP, Agudelo SP, Muñoz DL, Puerta JA, Vélez ID. Lack of efficacy of mefloquine in the treatment of new world cutaneous leishmaniasis in Colombia. Am J Trop Med Hyg 1998; 59: 889-892. Nivel de evidencia 2b, grado de recomendación B.

  89. Singh S, Sivakumar R. Challenges and new discoveries in the treatment of leishmaniasis. J Infect Chemother 2004; 10: 307-315.

  90. Soto J, Valda-Rodríquez L, Toledo J, Vera-Navarro L, Luz M, Monasterios- Torrico H, Vega J, Berman J. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis. Am J Trop Med Hyg 2004; 71: 577-581. Nivel de evidencia 1b, grado de recomendación A.

  91. Soto J, Toledo J, Vega J, Berman J. Short report: Efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis. Am J Trop Med Hyg 2005; 72: 421-422. Nivel de evidencia 2b, grado de recomendación B.

  92. Soto J, Toledo J, Gutiérrez P, Nicholls RS, Padilla J, Engel J, Fischer C, Voss A, Berman J. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis 2001; 33: E57-61. Nivel de evidencia 2b, grado de recomendación B.

  93. Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Díaz A, Luz M, Gutiérrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H. Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis 2004; 38: 1266-1272. Nivel de evidencia 1b, grado de recomendación A.

  94. Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, Junge K, Karbwang J, Bryceson AD, Berman JD. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis 2004; 38: 217-221. Nivel de evidencia 2b, grado de recomendación B.

  95. Sundar S, Jha TK, Sindermann H, Junge K, Bachmann P, Berman J. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis. Pediatr Infect Dis J 2003; 22: 434-438. Nivel de evidencia 2b, grado de recomendación B.

  96. Yardley V, Croft SL, DE Doncker S, Dujardin JC, Koirala S, Rijal S, Miranda C, Llanos-Cuentas A, Chappuis F. The sensitivity of clinical isolates of leishmania from Peru and Nepal to miltefosine. Am J Trop Med Hyg 2005; 73: 272-275.

  97. Franke ED, Llanos-Cuentas A, Echevarría J, Cruz ME, Campos P, Tovar AA, Lucas CM, Berman JD. Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis Am J Trop Med Hyg 1994; 51: 77-82. Nivel de evidencia 2b, grado de recomendación B.

  98. Thakur CP, Sinha GP, Pandey AK et al. Do the disminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first drug? An observational study of 80 cases. Am Trop Med Parasitol 1998; 30: 143-145.

  99. Castello MT, Echanove E, Ridocci F, Esteban E, Atienza F et al. Torsade de pointes durante el tratamiento de la leishmaniasis con antimonio de meglumina. Rev Esp Cardiol 1999; 52: 533-535.

  100. Soto J, Buffet P, Grogl M, Berman J. Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Trop Med Hyg 1994 Jan; 50 (1): 107-111. Nivel de evidencia 2b,l grado de recomendación B.

  101. Sereno D, Holzmuller P, Lemesre JL. Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum. Acta Trop 2000; 74: 25-31.

  102. Amato V, Amato J, Nicodemo A, Uip D, Amato-Neto V. Duarte M. Treatment of mucocutaneous leishmaniasis with pentamidine isothionate. Ann Dermatol Venereol 1998; 125: 492-495.




2020     |     www.medigraphic.com